Our results revealed elevated granzyme B expression in the lymph node CD8+ T-cells from dual IPI-549/PD-L1-treated tumor-bearing mice Compared to PD-L1 and IPI-549 single-treatment groups (Figure 7C). Here, GZMB is linked to neoplasm.